TMCNet:  Relatively Low Beta Detected in Shares of Telik in the Biotechnology Industry (TELK, PARD, ROSG, MDVN, QLTI)

[June 02, 2013]

Relatively Low Beta Detected in Shares of Telik in the Biotechnology Industry (TELK, PARD, ROSG, MDVN, QLTI)

Jun 02, 2013 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the lowest betas. Lower-beta stocks mean minimal volatility and are therefore generally considered to be a less risk and offer more stable returns.Telik ranks lowest with a a beta of 0.1. Poniard Pharmaceuticals is next with a a beta of 0.4. Rosetta Genomics ranks third lowest with a a beta of 0.4.


Medivation follows with a a beta of 0.5, and QLT rounds out the bottom five with a a beta of 0.5.

SmarTrend recommended that its subscribers protect gains by selling shares of Telik on January 18th, 2013 by issuing a Downtrend alert when the shares were trading at $1.74. Since that call, shares of Telik have fallen 18.7%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Write to Chip Brian at cbrian@mysmartrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To Cloud Computing 's Homepage ]